A Prospective, Open Label, Randomized Phase II Trial of Weekly Docetaxel Versus Weekly Vinorelbine as First Line Chemotherapy in Patients With Androgen Independent Prostate Cancer
To access this article, please choose from the options below
PII: S0022-5347(07)00286-8
doi:10.1016/j.juro.2007.01.148
© 2007 American Urological Association. Published by Elsevier Inc. All rights reserved.

